Literature DB >> 12055853

Molecular markers for species identification in the Leishmania subgenus Viannia.

Alexis Mendoza-León1, Luis Luis, Octavio Fernandes, Elisa Cupolillo, Lineth García.   

Abstract

We have previously identified a novel genomic sequence of 500 bp, the beta 500-DNA sequence, in the subgenus Leishmania (Viannia). This sequence was localized upstream of the beta-tubulin gene. Restriction fragment length polymorphism and hybridization analysis has shown that the beta 500-DNA sequence is specific to this subgenus. A polymerase chain reaction (PCR) assay confirmed this specificity. The beta 500-DNA sequence was apparently absent from the genomic deoxyribonucleic acid of L. colombiensis and L. equatoriensis. These results indicate that a PCR assay based on the beta 500-DNA sequence is likely to be of use to detect and identify Leishmania parasites of this subgenus in clinical samples with high sensitivity, specificity and reliability. The beta 500-DNA sequence can be considered a molecular marker for the subgenus Viannia.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12055853     DOI: 10.1016/s0035-9203(02)90053-2

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  2 in total

1.  Amiodarone and miltefosine act synergistically against Leishmania mexicana and can induce parasitological cure in a murine model of cutaneous leishmaniasis.

Authors:  Xenón Serrano-Martín; Gilberto Payares; Marisel De Lucca; Juan Carlos Martinez; Alexis Mendoza-León; Gustavo Benaim
Journal:  Antimicrob Agents Chemother       Date:  2009-10-05       Impact factor: 5.191

2.  Triatoma maculata, the Vector of Trypanosoma cruzi, in Venezuela. Phenotypic and Genotypic Variability as Potential Indicator of Vector Displacement into the Domestic Habitat.

Authors:  Roberto García-Alzate; Daisy Lozano-Arias; Rafael Matías Reyes-Lugo; Antonio Morocoima; Leidi Herrera; Alexis Mendoza-León
Journal:  Front Public Health       Date:  2014-09-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.